{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:45Z","timestamp":1792784445002,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"FIBAO","id":[{"id":"https:\/\/ror.org\/01s9yx644","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13300-025-01703-0","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:54:52Z","timestamp":1740704092000},"page":"569-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Proposed Practical Guidelines to Improve Glycaemic Management by Reducing Glycaemic Variability in People with Type 1 Diabetes Mellitus"],"prefix":"10.1007","volume":"16","author":[{"given":"Alejandra","family":"de Torres-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-0901","authenticated-orcid":false,"given":"Francisco J.","family":"Ampudia-Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraf\u00edn","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mezquita-Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"1","key":"1703_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Sun B, Huang S, Zhu C, Bian M. Glycemic variability: adverse clinical outcomes and how to improve it? Cardiovasc Diabetol. 2020;19(1):102.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1703_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/medicina60010061","volume":"60","author":"S Lazar","year":"2023","unstructured":"Lazar S, Ionita I, Reurean-Pintilei D, Timar B. How to measure glycemic variability? A literature review. Medicina (Kaunas). 2023;60(1):61.","journal-title":"Medicina (Kaunas)"},{"key":"1703_CR3","first-page":"P325","volume":"81","author":"C Gomes da Costa","year":"2022","unstructured":"Gomes da Costa C, Matos T, Vale S. Association between the coefficient of glycemic variation and time in range, below and above range in continuous monitoring glucose systems in type 1 diabetes. Endocr Abstr. 2022;81:P325.","journal-title":"Endocr Abstr"},{"key":"1703_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2337\/db12-1610","volume":"62","author":"JH DeVries","year":"2013","unstructured":"DeVries JH. Glucose variability: where it is important and how to measure it. Diabetes. 2013;62:1405\u20138.","journal-title":"Diabetes"},{"key":"1703_CR5","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1089\/dia.2018.0092","volume":"20","author":"D Rodbard","year":"2018","unstructured":"Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther. 2018;20:S25-215.","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"1703_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1177\/19322968221088601","volume":"17","author":"V Bellido","year":"2023","unstructured":"Bellido V, Aguilera E, Cardona-Hernandez R, et\u00a0al. Expert recommendations for using time-in-range and other continuous glucose monitoring metrics to achieve patient-centered glycemic control in people with diabetes. J Diabetes Sci Technol. 2023;17(5):1326\u201336.","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"1703_CR7","doi-asserted-by":"publisher","first-page":"108232","DOI":"10.1016\/j.jdiacomp.2022.108232","volume":"37","author":"H Chatwin","year":"2023","unstructured":"Chatwin H, Broadley M, Hendrieckx C, Hypo-RESOLVE Consortium, et\u00a0al. The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: results from \u201cYourSAY: Hypoglycaemia.\u201d J Diabetes Complic. 2023;37(11):108232.","journal-title":"J Diabetes Complic"},{"key":"1703_CR8","doi-asserted-by":"publisher","first-page":"108752","DOI":"10.1016\/j.diabres.2021.108752","volume":"174","author":"H Chatwin","year":"2021","unstructured":"Chatwin H, Broadley M, Speight J, Hypo-RESOLVE Consortium, et\u00a0al. The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: a systematic review. Diabetes Res Clin Pract. 2021;174:108752.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1703_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00592-024-02241-0","volume":"61","author":"L Zhang","year":"2024","unstructured":"Zhang L, Sun XX, Tian QS. Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications. Acta Diabetol. 2024;61(6):679\u201392.","journal-title":"Acta Diabetol"},{"issue":"1","key":"1703_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-020-01200-7","volume":"20","author":"B Sun","year":"2021","unstructured":"Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20(1):9.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"1703_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.diabet.2019.01.012","volume":"45","author":"M Benalia","year":"2019","unstructured":"Benalia M, Zeller M, Mouhat B, et\u00a0al. Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction. Diabetes Metab. 2019;45(5):446\u201352.","journal-title":"Diabetes Metab"},{"issue":"4","key":"1703_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2337\/dc18-2047","volume":"42","author":"E Gerbaud","year":"2019","unstructured":"Gerbaud E, Darier R, Montaudon M, et\u00a0al. Glycemic variability is a powerful independent predictive factor of midterm major adverse cardiac events in patients with diabetes with acute coronary syndrome. Diabetes Care. 2019;42(4):674\u201381.","journal-title":"Diabetes Care"},{"issue":"12","key":"1703_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006757","volume":"6","author":"A Wang","year":"2017","unstructured":"Wang A, Liu X, Xu J, et\u00a0al. Visit-to-visit variability of fasting plasma glucose and the risk of cardiovascular disease and all-cause mortality in the general population. J Am Heart Assoc. 2017;6(12): e006757.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1703_CR14","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00125-020-05273-7","volume":"63","author":"JJ Zhou","year":"2020","unstructured":"Zhou JJ, Coleman R, Holman RR, Reaven P. Long-term glucose variability and risk of nephropathy complication in UKPDS, ACCORD and VADT trials. Diabetologia. 2020;63(11):2482\u20135.","journal-title":"Diabetologia"},{"key":"1703_CR15","doi-asserted-by":"publisher","first-page":"204062231989837","DOI":"10.1177\/2040622319898370","volume":"11","author":"CL Lee","year":"2020","unstructured":"Lee CL, Chen CH, Wu MJ, Tsai SF. The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes. Ther Adv Chronic Dis. 2020;11:2040622319898370.","journal-title":"Ther Adv Chronic Dis"},{"key":"1703_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3389\/fendo.2020.00644","volume":"11","author":"MMB Christensen","year":"2020","unstructured":"Christensen MMB, Hommel EE, J\u00f8rgensen ME, Fleischer J, Hansen CS. Glycemic variability and diabetic neuropathy in young adults with type 1 diabetes. Front Endocrinol (Lausanne). 2020;11:644.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1703_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13098-018-0371-0","volume":"10","author":"M Akaza","year":"2018","unstructured":"Akaza M, Akaza I, Kanouchi T, Sasano T, Sumi Y, Yokota T. Nerve conduction study of the association between glycemic variability and diabetes neuropathy. Diabetol Metab Syndr. 2018;10:69.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"1703_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.diabet.2018.01.015","volume":"44","author":"YW Pai","year":"2018","unstructured":"Pai YW, Lin CH, Lee IT, Chang MH. Variability of fasting plasma glucose and the risk of painful diabetic peripheral neuropathy in patients with type 2 diabetes. Diabetes Metab. 2018;44(2):129\u201334.","journal-title":"Diabetes Metab"},{"issue":"10","key":"1703_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1212\/WNL.0000000000003682","volume":"88","author":"CP Yang","year":"2017","unstructured":"Yang CP, Li CI, Liu CS, et\u00a0al. Variability of fasting plasma glucose increased risks of diabetic polyneuropathy in T2DM. Neurology. 2017;88(10):944\u201351.","journal-title":"Neurology"},{"issue":"5","key":"1703_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/aos.13815","volume":"96","author":"V Schreur","year":"2018","unstructured":"Schreur V, van Asten F, Ng H, et\u00a0al. Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus. Acta Ophthalmol. 2018;96(5):459\u201364.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"1703_CR21","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1111\/dom.13842","volume":"21","author":"EG Wilmot","year":"2019","unstructured":"Wilmot EG, Choudhary P, Leelarathna L, Baxter M. Glycaemic variability: the under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes Metab. 2019;21(12):2599\u2013608.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1703_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/jdi.12551","volume":"8","author":"H Mori","year":"2017","unstructured":"Mori H, Okada Y, Kurozumi A, Narisawa M, Tanaka Y. Factors influencing interday glycemic variability in diabetic outpatients receiving insulin therapy. J Diabetes Investig. 2017;8(1):69\u201374.","journal-title":"J Diabetes Investig"},{"issue":"42","key":"1703_CR23","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"1","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et\u00a0al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;1(42):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"1","key":"1703_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/occmed\/kqs176","volume":"63","author":"J Young","year":"2013","unstructured":"Young J, Waclawski E, Young JA, Spencer J. Control of type 1 diabetes mellitus and shift work. Occup Med (Lond). 2013;63(1):70\u20132.","journal-title":"Occup Med (Lond)"},{"issue":"12","key":"1703_CR25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.15537\/smj.2021.42.12.20210416","volume":"42","author":"MA Albishri","year":"2021","unstructured":"Albishri MA, Alsubaie DM, Abugad HA, Abdel Wahab MM. Association between glycemic control and shift working among healthcare workers with diabetes, Dammam, Saudi Arabia: five years\u2019 experience. Saudi Med J. 2021;42(12):1296\u2013301.","journal-title":"Saudi Med J"},{"issue":"5","key":"1703_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/dia.2020.0495","volume":"23","author":"MC Riddell","year":"2021","unstructured":"Riddell MC, Li Z, Beck RW, et\u00a0al. More time in glucose range during exercise days than sedentary days in adults living with type 1 diabetes. Diabetes Technol Ther. 2021;23(5):376\u201383.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"1703_CR27","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1111\/dom.15277","volume":"25","author":"LCA Drenthen","year":"2023","unstructured":"Drenthen LCA, Ajie M, Bakker EA, et\u00a0al. Daily unstructured physical activity affects mean glucose, occurrence of hypoglycaemia and glucose variability in people with type 1 diabetes. Diabetes Obes Metab. 2023;25(12):3837\u201340.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"1703_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41574-022-00756-6","volume":"19","author":"MC Riddell","year":"2023","unstructured":"Riddell MC, Peters AL. Exercise in adults with type 1 diabetes mellitus. Nat Rev Endocrinol. 2023;19(2):98\u2013111.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1703_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","volume":"5","author":"MC Riddell","year":"2017","unstructured":"Riddell MC, Gallen IW, Smart CE, et\u00a0al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2017;5(5):377\u201390.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1703_CR30","first-page":"1","volume":"7","author":"JR Sparks","year":"2022","unstructured":"Sparks JR, Sarzynski MA, Davis JM, Grandjean PW, Wang X. Cross-sectional and individual relationships between physical activity and glycemic variability. Transl J Am Coll Sports Med. 2022;7(4):1\u201312.","journal-title":"Transl J Am Coll Sports Med"},{"key":"1703_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.767152","volume":"12","author":"X Zhu","year":"2021","unstructured":"Zhu X, Zhao L, Chen J, et\u00a0al. The effect of physical activity on glycemic variability in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2021;12: 767152.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1703_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.smhs.2021.09.004","volume":"3","author":"JR Sparks","year":"2021","unstructured":"Sparks JR, Kishman EE, Sarzynski MA, et\u00a0al. Glycemic variability: importance, relationship with physical activity, and the influence of exercise. Sports Med Health Sci. 2021;3(4):183\u201393.","journal-title":"Sports Med Health Sci"},{"issue":"4","key":"1703_CR33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2337\/dc22-1721","volume":"46","author":"MC Riddell","year":"2023","unstructured":"Riddell MC, Li Z, Gal RL, T1DEXI Study Group, et\u00a0al. Examining the acute glycemic effects of different types of structured exercise sessions in type 1 diabetes in a real-world setting: the type 1 diabetes and exercise initiative (T1DEXI). Diabetes Care. 2023;46(4):704\u201313.","journal-title":"Diabetes Care"},{"issue":"1","key":"1703_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2337\/dc23-1548","volume":"47","author":"MC Riddell","year":"2024","unstructured":"Riddell MC, Gal RL, Bergford S, et\u00a0al. The acute effects of real-world physical activity on glycemia in adolescents with type 1 diabetes: the type 1 diabetes exercise initiative pediatric (T1DEXIP) study. Diabetes Care. 2024;47(1):132\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"1703_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101361","volume":"48","author":"S Murillo","year":"2022","unstructured":"Murillo S, Brugnara L, Servitja JM, Novials A. High intensity interval training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes: HIIT and hypoglycemia in type 1 diabetes. Diabetes Metab. 2022;48(6): 101361.","journal-title":"Diabetes Metab"},{"key":"1703_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjcard.2024.07.028","volume":"228","author":"TBFS Martins","year":"2024","unstructured":"Martins TBFS, Gomes OV, Soltani P, Oliveira THR, de Brito-Gomes JL. Sex-related glycemic and cardiovascular responses after continuous and interval aerobic sessions in patients with type 1 diabetes: a randomized crossover study. Am J Cardiol. 2024;228:48\u201355.","journal-title":"Am J Cardiol"},{"issue":"11","key":"1703_CR37","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2337\/dc16-1728","volume":"39","author":"SR Colberg","year":"2016","unstructured":"Colberg SR, Sigal RJ, Yardley JE, et\u00a0al. Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065\u201379.","journal-title":"Diabetes Care"},{"issue":"8","key":"1703_CR38","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/pedi.13452","volume":"23","author":"P Adolfsson","year":"2022","unstructured":"Adolfsson P, Taplin CE, Zaharieva DP, et\u00a0al. ISPAD clinical practice consensus guidelines 2022: exercise in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1341\u201372.","journal-title":"Pediatr Diabetes"},{"key":"1703_CR39","unstructured":"Healthy Living with Diabetes. National Institute of Diabetes and Digestive and Kidney Diseases. https:\/\/www.niddk.nih.gov\/health-information\/diabetes\/overview\/dieteating-physical-activity. Accessed 4 Oct 2024."},{"issue":"7367","key":"1703_CR40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","volume":"325","author":"DAFNE Study Group","year":"2002","unstructured":"DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ. 2002;325(7367):746.","journal-title":"BMJ"},{"issue":"5","key":"1703_CR41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dci19-0014","volume":"42","author":"AB Evert","year":"2019","unstructured":"Evert AB, Dennison M, Gardner CD, et\u00a0al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019;42(5):731\u201354.","journal-title":"Diabetes Care"},{"issue":"8","key":"1703_CR42","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/pedi.13429","volume":"23","author":"SF Annan","year":"2022","unstructured":"Annan SF, Higgins LA, Jelleryd E, et\u00a0al. ISPAD clinical practice consensus guidelines 2022: nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1297\u2013321.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"1703_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/nu16010162","volume":"16","author":"SR Patton","year":"2024","unstructured":"Patton SR, Bergford S, Sherr JL, et\u00a0al. Postprandial glucose variability following typical meals in youth living with type 1 diabetes. Nutrients. 2024;16(1):162.","journal-title":"Nutrients"},{"key":"1703_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-nutr-121214-104422","volume":"35","author":"J Tay","year":"2015","unstructured":"Tay J, Thompson CH, Brinkworth GD. Glycemic variability: assessing glycemia differently and the implications for dietary management of diabetes. Annu Rev Nutr. 2015;35:389\u2013424.","journal-title":"Annu Rev Nutr"},{"key":"1703_CR45","unstructured":"Glycemic Index Food Guide. Diabetes Canada. https:\/\/www.diabetes.ca\/DiabetesCanadaWebsite\/media\/Managing-My-Diabetes\/Tools%20and%20Resources\/glycemic-index-food-guide.pdf?ext=.pdf. Accessed 4 Oct 2024."},{"key":"1703_CR46","unstructured":"Glycemic Index Chart: GI Ratings for Hundreds of Foods. University Health News Daily. https:\/\/universityhealthnews.com\/daily\/nutrition\/glycemic-index-chart\/. Accessed 4th Oct 2024."},{"key":"1703_CR47","unstructured":"Glycemic Index and Load. Free mobile app. Glycemic index guide. https:\/\/glycemic-index.net\/. Accessed 4th Oct 2024."},{"key":"1703_CR48","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2337\/dc15-2855","volume":"39","author":"KJ Bell","year":"2016","unstructured":"Bell KJ, Toschi E, Steil GM, Wolpert HA. Optimized mealtime insulin dosing for fat and protein in type 1 diabetes: application of a model-based approach to derive insulin doses for open-loop diabetes management. Diabetes Care. 2016;39:1631\u20134.","journal-title":"Diabetes Care"},{"key":"1703_CR49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/pedi.12674","volume":"19","author":"T Smith","year":"2018","unstructured":"Smith T, Fuery M, Knight B, et\u00a0al. In young people using insulin pump therapy an additional sixty percent of the mealtime insulin dose improves postprandial glycaemia following a high fat, high protein meal (abstract). Pediatr Diabetes. 2018;19:131\u20132.","journal-title":"Pediatr Diabetes"},{"key":"1703_CR50","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/dc12-0092","volume":"36","author":"HA Wolpert","year":"2013","unstructured":"Wolpert HA, Atakov-Castillo A, Smith SA, Steil GM. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care. 2013;36:810\u20136.","journal-title":"Diabetes Care"},{"key":"1703_CR51","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.2337\/dc13-1195","volume":"36","author":"CE Smart","year":"2013","unstructured":"Smart CE, Evans M, O\u2019Connell SM, et\u00a0al. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care. 2013;36:3897\u2013902.","journal-title":"Diabetes Care"},{"key":"1703_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2337\/dc19-0687","volume":"43","author":"KJ Bell","year":"2020","unstructured":"Bell KJ, Fio CZ, Twigg S, et\u00a0al. Amount and type of dietary fat, postprandial glycemia, and insulin requirements in type 1 diabetes: a randomized within-subject trial. Diabetes Care. 2020;43:59\u201366.","journal-title":"Diabetes Care"},{"key":"1703_CR53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/dom.14390","volume":"23","author":"C Dimosthenopoulos","year":"2021","unstructured":"Dimosthenopoulos C, Liatis S, Kourpas E, et\u00a0al. The beneficial short-term effects of a high-protein\/low-carbohydrate diet on glycaemic control assessed by continuous glucose monitoring in patients with type 1 diabetes. Diabetes Obes Metab. 2021;23:1765\u201374.","journal-title":"Diabetes Obes Metab"},{"key":"1703_CR54","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3390\/nu15081981","volume":"15","author":"FR Muntis","year":"2023","unstructured":"Muntis FR, Smith-Ryan AE, Crandell J, et\u00a0al. A High protein diet is associated with improved glycemic control following exercise among adolescents with type 1 diabetes. Nutrients. 2023;15:1981.","journal-title":"Nutrients"},{"key":"1703_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/dme.13525","volume":"35","author":"D Slattery","year":"2018","unstructured":"Slattery D, Amiel SA, Choudhary P. Optimal prandial timing of bolus insulin in diabetes management: a review. Diabet Med. 2018;35:306\u201316.","journal-title":"Diabet Med"},{"issue":"1","key":"1703_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41387-020-0109-6","volume":"10","author":"CJ Henry","year":"2020","unstructured":"Henry CJ, Kaur B, Quek RYC. Chrononutrition in the management of diabetes. Nutr Diabetes. 2020;10(1):6.","journal-title":"Nutr Diabetes"},{"issue":"6","key":"1703_CR57","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00125-023-05894-8","volume":"66","author":"Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD)","year":"2023","unstructured":"Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023;66(6):965\u201385.","journal-title":"Diabetologia"},{"issue":"1","key":"1703_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41387-022-00196-1","volume":"12","author":"S Strozyk","year":"2022","unstructured":"Strozyk S, Rogowicz-Frontczak A, Pilacinski S, LeThanh-Blicharz J, Koperska A, Zozulinska-Ziolkiewicz D. Influence of resistant starch resulting from the cooling of rice on postprandial glycemia in type 1 diabetes. Nutr Diabetes. 2022;12(1):21.","journal-title":"Nutr Diabetes"},{"issue":"2","key":"1703_CR59","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jan.14255","volume":"76","author":"LJ Cheng","year":"2020","unstructured":"Cheng LJ, Jiang Y, Wu VX, Wang W. A systematic review and meta-analysis: vinegar consumption on glycaemic control in adults with type 2 diabetes mellitus. J Adv Nurs. 2020;76(2):459\u201374.","journal-title":"J Adv Nurs"},{"key":"1703_CR60","doi-asserted-by":"publisher","first-page":"1036717","DOI":"10.3389\/fnut.2023.1036717","volume":"10","author":"FS Atkinson","year":"2023","unstructured":"Atkinson FS, Cohen M, Lau K, Brand-Miller JC. Glycemic index and insulin index after a standard carbohydrate meal consumed with live kombucha: a randomised, placebo-controlled, crossover trial. Front Nutr. 2023;10:1036717.","journal-title":"Front Nutr"},{"issue":"1","key":"1703_CR61","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s40001-024-01946-w","volume":"29","author":"E Resmini","year":"2024","unstructured":"Resmini E, Zarra E, Dotti S, et\u00a0al. Impact on glycemia risk index and other metrics in type 1 adult patients switching to advanced hybrid closed-loop systems: a one-year real-life experience. Eur J Med Res. 2024;29(1):365.","journal-title":"Eur J Med Res"},{"issue":"10","key":"1703_CR62","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/dc23-0635","volume":"46","author":"TSJ Crabtree","year":"2023","unstructured":"Crabtree TSJ, Griffin TP, Yap YW, ABCD Closed-Loop Audit Contributors, et\u00a0al. hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study. Diabetes Care. 2023;46(10):1831\u20138.","journal-title":"Diabetes Care"},{"issue":"2","key":"1703_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15015","volume":"40","author":"SM Ng","year":"2023","unstructured":"Ng SM, Wright NP, Yardley D, et\u00a0al. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England. Diabet Med. 2023;40(2): e15015.","journal-title":"Diabet Med"},{"issue":"16","key":"1703_CR64","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.3390\/ijerph191610293","volume":"19","author":"B Bombaci","year":"2022","unstructured":"Bombaci B, Passanisi S, Alibrandi A, et\u00a0al. One-year real-world study on comparison among different continuous subcutaneous insulin infusion devices for the management of pediatric patients with type 1 diabetes: the supremacy of hybrid closed-loop systems. Int J Environ Res Public Health. 2022;19(16):10293.","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"1703_CR65","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1089\/dia.2022.0207","volume":"24","author":"J Moreno-Fernandez","year":"2022","unstructured":"Moreno-Fernandez J, Chico A, Mart\u00ednez-Brocca MA, SPAIP Registry Study, et\u00a0al. Continuous subcutaneous insulin infusion in type 1 diabetes mellitus patients: results from the Spanish National Registry. Diabetes Technol Ther. 2022;24(12):898\u2013906.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"1703_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s43856-023-00358-x","volume":"3","author":"LM Jacobsen","year":"2023","unstructured":"Jacobsen LM, Sherr JL, Considine E, ADA\/EASD PMDI, et\u00a0al. Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review. Commun Med (Lond). 2023;3(1):132.","journal-title":"Commun Med (Lond)."},{"issue":"1","key":"1703_CR67","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/1932296820955168","volume":"16","author":"CK Boughton","year":"2022","unstructured":"Boughton CK, Hartnell S, Allen JM, Fuchs J, Hovorka R. Training and support for hybrid closed-loop therapy. J Diabetes Sci Technol. 2022;16(1):218\u201323.","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"1703_CR68","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/dom.14273","volume":"23","author":"L Leelarathna","year":"2021","unstructured":"Leelarathna L, Choudhary P, Wilmot EG, et\u00a0al. Hybrid closed-loop therapy: where are we in 2021? Diabetes Obes Metab. 2021;23(3):655\u201360.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl1","key":"1703_CR69","first-page":"2","volume":"14","author":"D Mauricio","year":"2018","unstructured":"Mauricio D, Hramiak I. Second-generation insulin analogues - A review of recent real-world data and forthcoming head-to-head comparisons. Eur Endocrinol. 2018;14(Suppl1):2\u20139.","journal-title":"Eur Endocrinol"},{"issue":"8","key":"1703_CR70","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s13300-023-01423-3","volume":"14","author":"JE Black","year":"2023","unstructured":"Black JE, Harris SB, Ryan BL, Zou G, Ratzki-Leewing A. Real-world effects of second-generation versus earlier intermediate\/basal insulin analogues on rates of hypoglycemia in adults with type 1 and 2 diabetes (iNPHORM, US). Diabetes Ther. 2023;14(8):1299\u2013317.","journal-title":"Diabetes Ther"},{"issue":"1","key":"1703_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/dia.2020.0180","volume":"23","author":"T Battelino","year":"2021","unstructured":"Battelino T, Edelman SV, Nishimura R, Bergenstal RM. Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring. Diabetes Technol Ther. 2021;23(1):20\u201330.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"1703_CR72","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/dia.2021.0164","volume":"23","author":"S Robinson","year":"2021","unstructured":"Robinson S, Newson RS, Liao B, Kennedy-Martin T, Battelino T. Missed and mistimed insulin doses in people with diabetes: a systematic literature review. Diabetes Technol Ther. 2021;23(12):844\u201356.","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"1703_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/dom.12416","volume":"17","author":"RH Becker","year":"2015","unstructured":"Becker RH, Nowotny I, Teichert L, Bergmann K, Kapitza C. Low within- and between-day variability in exposure to new insulin glargine 300 U\/ml. Diabetes Obes Metab. 2015;17(3):261\u20137.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1703_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.diabres.2015.04.002","volume":"109","author":"J Vora","year":"2015","unstructured":"Vora J, Cariou B, Evans M, et\u00a0al. Clinical use of insulin degludec. Diabetes Res Clin Pract. 2015;109(1):19\u201331.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1703_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000802","volume":"3","author":"K Heitman","year":"2023","unstructured":"Heitman K, Thomas SE, Kelly O, et\u00a0al. Snacks contribute considerably to total dietary intakes among adults stratified by glycemia in the United States. PLoS Glob Public Health. 2023;3(10): e0000802.","journal-title":"PLoS Glob Public Health"},{"issue":"1","key":"1703_CR76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/nu10010109","volume":"10","author":"G Tascini","year":"2018","unstructured":"Tascini G, Berioli MG, Cerquiglini L, et\u00a0al. Carbohydrate counting in children and adolescents with type 1 diabetes. Nutrients. 2018;10(1):109.","journal-title":"Nutrients"},{"issue":"1","key":"1703_CR77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1932296819841911","volume":"14","author":"A Chico","year":"2020","unstructured":"Chico A, Aguilera E, Ampudia-Blasco FJ, et\u00a0al. Clinical approach to flash glucose monitoring: an expert recommendation. J Diabetes Sci Technol. 2020;14(1):155\u201364.","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"1703_CR78","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/dom.15204","volume":"25","author":"R Unsworth","year":"2023","unstructured":"Unsworth R, Avari P, Lett AM, Oliver N, Reddy M. Adaptive bolus calculators for people with type 1 diabetes: a systematic review. Diabetes Obes Metab. 2023;25(11):3103\u201313.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1703_CR79","volume":"16","author":"S Gupta","year":"2024","unstructured":"Gupta S, Ramteke H, Gupta S, Gupta S, Gupta KS. Are people with type 1 diabetes mellitus appropriately following insulin injection technique practices: a review of literature. Cureus. 2024;16(1): e51494.","journal-title":"Cureus"},{"issue":"7","key":"1703_CR80","first-page":"1087","volume":"9","author":"F Lombardo","year":"2022","unstructured":"Lombardo F, Bombaci B, Alibrandi A, Visalli G, Salzano G, Passanisi S. The impact of insulin-induced lipodystrophy on glycemic variability in pediatric patients with type 1 diabetes. Children (Basel). 2022;9(7):1087.","journal-title":"Children (Basel)"},{"key":"1703_CR81","doi-asserted-by":"publisher","first-page":"1205121","DOI":"10.1155\/2018\/1205121","volume":"2018","author":"AKJ Gradel","year":"2018","unstructured":"Gradel AKJ, Porsgaard T, Lykkesfeldt J, et\u00a0al. Factors affecting the absorption of subcutaneously administered insulin: effect on variability. J Diabetes Res. 2018;2018:1205121.","journal-title":"J Diabetes Res"},{"issue":"7","key":"1703_CR82","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s13300-023-01417-1","volume":"14","author":"C Tejera-P\u00e9rez","year":"2023","unstructured":"Tejera-P\u00e9rez C, Chico A, Azriel-Mira S, Lardi\u00e9s-S\u00e1nchez B, Gomez-Peralta F, \u00c1rea de Diabetes-SEEN. Connected insulin pens and caps: an expert\u2019s recommendation from the area of diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Ther. 2023;14(7):1077\u201391.","journal-title":"Diabetes Ther."},{"issue":"3","key":"1703_CR83","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/1932296820983863","volume":"16","author":"L Heinemann","year":"2022","unstructured":"Heinemann L, Schnell O, Gehr B, Schloot NC, G\u00f6rgens SW, G\u00f6rgen C. Digital diabetes management: a literature review of smart insulin pens. J Diabetes Sci Technol. 2022;16(3):587\u201395.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"1703_CR84","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12902-022-01013-7","volume":"22","author":"A D\u00e9niz-Garc\u00eda","year":"2022","unstructured":"D\u00e9niz-Garc\u00eda A, D\u00edaz-Artiles A, Saavedra P, Alvarado-Martel D, W\u00e4gner AM, Boronat M. Impact of anxiety, depression and disease-related distress on long-term glycaemic variability among subjects with type 1 diabetes mellitus. BMC Endocr Disord. 2022;22(1):122.","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"1703_CR85","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00125-021-05500-9","volume":"64","author":"R Brandt","year":"2021","unstructured":"Brandt R, Park M, Wroblewski K, Quinn L, Tasali E, Cinar A. Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes. Diabetologia. 2021;64(10):2159\u201369.","journal-title":"Diabetologia"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-025-01703-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-025-01703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T02:42:48Z","timestamp":1742524968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-025-01703-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1703"],"URL":"https:\/\/doi.org\/10.1007\/s13300-025-01703-0","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alejandra de Torres has the following financial relationships: lectures for Novo Nordisk, received grant support from Abbott and research activities from Novo Nordisk and Eli Lilly and Company. Francisco Javier Ampudia-Blasco has served as a consultant\/advisor for Abbott Diabetes Care, AstraZeneca, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, LifeScan, MannKind Co., Medtronic, Menarini, Merck, Novartis, Novo Nordisk and Sanofi; as a speaker for Abbott Diabetes Care, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, LifeScan, Eli Lilly, Madaus, Medtronic, Menarini, Merck, Novartis, Novo Nordisk and Sanofi; and has received grant support from Novo Nordisk and Sanofi. Virginia Bellido received consulting fees from Abbott, Eli Lilly, Novo Nordisk and Sanofi; received honoraria from Abbott, Astra Zeneca, Boehringer Ingelheim, Esteve, Eli Lilly, MSD, Mundipharma, Novo Nordisk and Sanofi; and received support to attend meetings from Abbott, Astra Zeneca, Boehringer Ingelheim, Esteve, Eli Lilly, MSD, Novo Nordisk and Sanofi. Antonio J. Amor has the following financial relationships: speaker for Novo Nordisk, Lilly, Sanofi and MSD. Pedro Mezquita-Raya has the following financial relationships: advisor on scientific boards for Abbott, Astra-Zeneca, FAES and Novo Nordisk; lectures for Astra-Zeneca, Eli Lilly and Company, FAES, Fresenius and Novo Nordisk; and research activities for Eli Lilly and Company and Novo Nordisk. Seraf\u00edn Murillo declares that he has no competing interests. Antonio J. Amor is an Editorial Board member of Diabetes Therapy. Antonio J. Amor was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies as well as on previous authors\u2019 observations and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Springer Healthcare is not responsible for the validity of the guidelines it publishes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Springer Healthcare\u2019s Disclosure"}}]}}